“The stakeholders should be congratulated. It is a win-win situation for all concerned,?said WTO Director-General Mike Moore.

“The settlement shows that the WTO’s Agreements, such as TRIPS, contain the necessary flexibility to meet the health needs of developing countries and can be used as a basis for resolving difficult issues concerning access to essential drugs.?/p>

For more information on TRIPS and pharmaceuticals, see the TRIPS section of the website.